Is the lower mortality in patients treated with aspirin and angiotensin-converting enzyme inhibitors due to decreased norepinephrine release? (multiple letter) (3)

Journal of the American College of Cardiology

Volumn 35, Issue 3, 2000, Pages 817-818

  Levi, Roberto ^a   Maruyama, Ryushi ^a   Smith, Neil C E ^a   Seyedi, Nahid ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BRADYKININ; CAPTOPRIL; CATECHOLAMINE; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INDOMETACIN; LOSARTAN; MOXONIDINE; NEUROHORMONE; NITRIC OXIDE; NORADRENALIN; PROSTACYCLIN; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; WARFARIN;

ARTERY ENDOTHELIUM; CARDIOVASCULAR RISK; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY DISEASE; DRUG SAFETY; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; LETTER; MORTALITY; NORADRENALIN RELEASE; PRIORITY JOURNAL; SYMPATHETIC NERVE; VASOCONSTRICTION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASPIRIN; BIOLOGICAL MARKERS; CORONARY DISEASE; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HEART FAILURE, CONGESTIVE; HUMANS; NOREPINEPHRINE; PLATELET AGGREGATION INHIBITORS; RISK FACTORS; SURVIVAL RATE;

EID: 0034162831     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00618-X     Document Type: Letter

References (10)

1. J. Leor H. Reicher-Reiss U. Goldbourt Aspirin and mortality in patients treated with angiotensin-converting enzyme inhibitors—a cohort study of 11,575 patients with coronary artery disease J Am Coll Cardiol 33 1999 1920 1925
2. A.G. Scicli Increases in cardiac kinins as a new mechanism to protect the heart Hypertension 23 1994 419 421
3. 2-receptor activation augments norepinephrine exocytosis from cardiac sympathetic nerve endings mediation by autocrine/paracrine mechanisms Circ Res 81 1997 774 784
4. E. Hatta R. Maruyama S.J. Marshall M. Imamura R. Levi Bradykinin promotes ischemic norepinephrine release in guinea pig and human hearts J Pharmacol Exp Ther 288 1999 919 927
5. N. Seyedi R. Maruyama R. Levi Bradykinin activates a cross-signaling pathway between sensory and adrenergic nerve endings in the heart a novel mechanism of ischemic norepinephrine release? J Pharmacol Exp Ther 290 1999 656 663
6. S.H. Kubo T.S. Rector A.J. Bank R.E. Williams S.M. Heifetz Endothelium-dependent vasodilation is attenuated in patients with heart failure Circulation 84 1991 1589 1596
7. R. Busse I. Fleming Endothelial dysfunction in atherosclerosis J Vasc Res 33 1996 181 194
8. J.A. Vita C.B. Treasure A.C. Yeung Patients with evidence of coronary endothelial dysfunction as assessed by acetylcholine infusion demonstrate marked increase in sensitivity to constrictor effects of catecholamines Circulation 85 1992 1390 1397
9. B. Pitt R. Segal F.A. Martinez Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly [ELITE] Study) Lancet 349 1997 747 752
10. C.R. Benedict B. Shelton D.E. Johnstone Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction Circulation 94 1996 690 697